|
|
هفتمین همایش بیو انفورماتیک ایران
|
|
|
| عنوان فارسی |
|
|
| چکیده فارسی مقاله |
|
|
| کلیدواژه‌های فارسی مقاله |
|
|
| عنوان انگلیسی |
Role of Glycosylation in Developing Anti-cancer Therapeutics |
|
| چکیده انگلیسی مقاله |
Membrane embedded proteins are the key players in cancerous cells [1]. Almost all of the membrane proteins are glycosylated with sugar moieties (glycans) [2]. These attached glycans are known to play crucial roles in the structure, function and dynamics of the membrane proteins [3]. However, the atomistic mechanism behind these roles and their potential implementation in efficient anti-cancer drug design are poorly studied [3]. Here atomistic molecular dynamics simulations were used to investigate the role of attached glycans in the ligand binding of the Epidermal Growth Factor Receptor (EGFR) that is a tyrosine kinase associated with several cancers [4]. Auto-inhibited monomeric form of EGFR becomes untethered by binding of the growth factors to its extracellular domain [5]. The interaction between two untethered monomers forms the back-to-back dimeric construct, known to be the active form of EGFR [6]. Several antibodies are designed to inhibit EGFR by binding to the glycosylated extracellular domain [5, 7-9]. It was shown that glycosylation promotes binding affinity of EGFR for the growth factors by stabilizing the growth factor binding site and facilitates dimerization by maintaining the dimeric interfaces [3]. Glycosylation also plays various roles in the binding of antibodies to different epitopes of the EGFR extracellular domain [3]. Glycosylation seems to affect the binding affinity of monoclonal antibody 806 (mAb806) to EGFR by exposing a cryptic pocket in the extracellular domain. These findings could lead to efficient drug design for membrane proteins involved in cancer and could be expanded by designing glycan-based antibodies functioning with the glycan-glycan interactions between the target protein and the drug in cancerous cells. |
|
| کلیدواژه‌های انگلیسی مقاله |
Glycosylation, Monoclonal antibody. |
|
| نویسندگان مقاله |
Maryam Azimzadeh Irani - School of Biological Sciences, Nanyang Technological University, 60 Nanyang Drive
|
|
| نشانی اینترنتی |
http://www.icb7.ir |
| فایل مقاله |
دریافت فایل مقاله |
| کد مقاله (doi) |
|
| زبان مقاله منتشر شده |
en |
| موضوعات مقاله منتشر شده |
|
| نوع مقاله منتشر شده |
|
|
|
|
برگشت به:
صفحه اول پایگاه |
دوره مرتبط |
کنفرانس مرتبط |
فهرست کنفرانس ها
|
